Article citationsMore>>

Lyu, Q., et al. (2020) Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit from Immune Checkpoint Inhibition. Cancer Control: Journal of the Moffitt Cancer Center, 27, Paper No. 1073274820976665.
https://doi.org/10.1177/1073274820976665

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top